Skip to main content

Table 2 APO E - CI - CII haplotype distribution in CAD and control subjects.

From: Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

Haplotype

Control

CAD

E2 - H1 - A1

0.0107

-

E2 - H1 - A2

-

-

E2 - H2 - A1

0.0342

0.0191

E2 - H2 - A2

-

0.0183

E3 - H1 - A1

0.4155

0.4107

E3 - H1 - A2

0.4216

0.4446

E3 - H2 - A1

0.0167

0.0196

E3 - H2 - A2

0.0160

-

E4 - H1 - A1

0.0596

0.03836

E4 - H1 - A2

0.0072

-

E4 - H2 - A1

0.0180

0.0247

E4 - H2 - A2

-

0.0244

P

0.922

 
  1. P: Probability values for the comparison of haplotype frequencies between controls and CAD.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X